GlassScriptPhysician profile
Amber A Jackson
NPI 1801263413
$3,855.27
in general payments reported to CMS, 2019-2025
21 companies · $1,355 in 2025
The $1,355 reported for 2025 was more than what 89% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $411 · 2022: $226 · 2023: $928 · 2024: $935 · 2025: $1,355.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,218.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,022.63 | 2021-2025 | |
| Madrigal Pharmaceuticals | $383.25 | 2024-2025 | Rezdiffra, Resmetirom |
| Ipsen Biopharmaceuticals, INC | $246.77 | 2024-2025 | Iqirvo |
| Gilead Sciences, INC. | $229.26 | 2021-2024 | |
| Medtronic, INC. | $146.40 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $117.76 | 2021-2025 | Gattex, Eohilia |
| Ardelyx, INC. | $102.88 | 2023-2025 | Ibsrela |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $78.72 | 2022-2025 | Xifaxan |
| Aimmune Therapeutics, INC. | $70.40 | 2025 | Zenpep, Vowst |
| Daiichi Sankyo INC. | $70.13 | 2021-2024 | Injectafer |
| Neuraxis, INC. | $67.25 | 2025 | |
| Lilly USA, LLC | $45.20 | 2024 | Omvoh |
| Ferring Pharmaceuticals INC. | $44.01 | 2023-2025 | Rebyota |
| Qol Medical, LLC | $37.75 | 2025 | Sucraid |
| Arcutis Biotherapeutics, INC. | $35.87 | 2024-2025 | Zoryve |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $35.45 | 2025 | Terlivaz |
| Evoke Pharma, INC. | $34.83 | 2024 | |
| Novo Nordisk INC | $27.68 | 2025 | Wegovy |
| Sandoz INC. | $24.50 | 2025 | Hyrimoz |
| Organon LLC | $22.97 | 2025 | Hadlima |
| Nestle Healthcare Nutrition INC. | $11.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.